Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
almotriptan (axert) (1 trial)
erenumab (aimovig) (1 trial)
fremanezumab (Ajovy) (1 trial)
frovatriptan (frova) (1 trial)
levobupivacaine (chirocaine) (1 trial)
naproxen (naprosyn) (5 trials)
naratriptan (amerge) (1 trial)
pseudoephedrine (Benylin) (1 trial)
rimabotulinumtoxinB (Myobloc) (3 trials)
rizatriptan (maxalt) (1 trial)
sodium chloride (2 trials)
sumatriptan (zecuity) (5 trials)
topiramate (topamax) (2 trials)
magnesium lactate (1 trial)
carbon dioxide (dry ice) (1 trial)
corticotropin (acthar) (1 trial)
ionis-pkkrx (1 trial)
loxapine (loxitane) (1 trial)
vvd-101 (1 trial)
Cognitive Dysfunction (Phase 4)
Disease Progression (Phase 4)
Headache (Phase 4)
Migraine Disorders (Phase 4)
Post-Traumatic Headache (Phase 4)
Premenstrual Syndrome (Phase 4)
Sinusitis (Phase 4)
Trials (22 total)
Trial APIs (19 total)